Outlining the implications of this c-suite trend for pharma.
Michael Abrams, MA
Advertisement
Articles by Michael Abrams, MA
Commercial-model shift demanding greater influence of these teams.
Advertisement
Latest Updated Articles
Time for Pharma to Reimagine the Medical Affairs RolePublished: June 9th 2021 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Stock Reacts to Recent Board Changes
2
MJH Life Sciences Acquires BPD Healthcare, Expands Reach Among Health Systems and Innovators
3
Bob Mauch: Strengthening the Chain
4
Takeda and Innovent Biologics Announce Strategic Global Partnership
5
